PT92071A - Processo de preparacao de imunotoxinas e de preparados farmaceuticos para o tratamento ou profilaxia de doencas auto-imunes - Google Patents
Processo de preparacao de imunotoxinas e de preparados farmaceuticos para o tratamento ou profilaxia de doencas auto-imunesInfo
- Publication number
- PT92071A PT92071A PT92071A PT9207189A PT92071A PT 92071 A PT92071 A PT 92071A PT 92071 A PT92071 A PT 92071A PT 9207189 A PT9207189 A PT 9207189A PT 92071 A PT92071 A PT 92071A
- Authority
- PT
- Portugal
- Prior art keywords
- auto
- treatment
- prophylaxia
- immunotoxins
- pharmaceutical preparations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
- A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
- A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
- A61K47/6817—Toxins
- A61K47/6819—Plant toxins
- A61K47/6825—Ribosomal inhibitory proteins, i.e. RIP-I or RIP-II, e.g. Pap, gelonin or dianthin
- A61K47/6827—Ricin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Toxicology (AREA)
- Botany (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Molecular Biology (AREA)
- Transplantation (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP88202349 | 1988-10-21 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PT92071A true PT92071A (pt) | 1990-04-30 |
| PT92071B PT92071B (pt) | 1995-06-30 |
Family
ID=8199870
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT92071A PT92071B (pt) | 1988-10-21 | 1989-10-20 | Processo de preparacao de imunotoxinas e de preparados farmaceuticos para o tratamento ou profilaxia de doencas auto-imunes |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0365087B1 (pt) |
| JP (1) | JP2807506B2 (pt) |
| KR (1) | KR0151851B1 (pt) |
| AT (1) | ATE78407T1 (pt) |
| AU (1) | AU625802B2 (pt) |
| CA (1) | CA2000999A1 (pt) |
| DE (1) | DE68902212T2 (pt) |
| DK (1) | DK523589A (pt) |
| ES (1) | ES2051989T3 (pt) |
| FI (1) | FI100305B (pt) |
| GR (1) | GR3006048T3 (pt) |
| IE (1) | IE61831B1 (pt) |
| NZ (1) | NZ231095A (pt) |
| PT (1) | PT92071B (pt) |
| ZA (1) | ZA897895B (pt) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU3423293A (en) * | 1991-12-19 | 1993-07-19 | Baylor College Of Medicine | Pva or peg conjugates of peptides for epitope-specific immunosuppression |
| WO2000009155A1 (en) | 1998-08-11 | 2000-02-24 | Rush-Presbyterian-St.Luke's Medical Center | Methods and compositions for preventing anti-gal production in xenograft recipients |
| KR100346059B1 (ko) * | 1999-12-30 | 2002-07-24 | 주식회사 효성 | 폴리에스테르 섬유의 제조방법 |
| AU2007323134B2 (en) * | 2006-11-23 | 2013-05-02 | Cadila Pharmaceuticals Limited | Poly-TLR antagonist |
| JP7303107B2 (ja) | 2016-08-12 | 2023-07-04 | イムノワーク，リミテッド ライアビリティ カンパニー | 自己免疫疾患の診断、予防、および／または治療 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL69686A (en) * | 1983-09-11 | 1988-03-31 | Yeda Res & Dev | Compositions containing cell membrane proteins and process for their preparation |
| DE3513572A1 (de) * | 1985-04-16 | 1986-10-16 | Karl Prof. Dr.med. 7302 Ostfildern Theurer | Herstellung von praeparaten zur spezifischen beeinflussung der humoralen und zellulaeren immunreaktion |
| NL8701163A (nl) * | 1986-09-09 | 1988-04-05 | Nederlanden Staat | Gebruik van een peptide voor de bereiding van preparaten voor het verlichten, het behandelen en de diagnose van autoimmuunziekten, in het bijzonder arthritische toestanden, verbindingen die met dit peptide verwant zijn, alsmede farmaceutische en diagnostische preparaten en testkits. |
-
1989
- 1989-10-13 ES ES89202588T patent/ES2051989T3/es not_active Expired - Lifetime
- 1989-10-13 AT AT89202588T patent/ATE78407T1/de not_active IP Right Cessation
- 1989-10-13 DE DE8989202588T patent/DE68902212T2/de not_active Expired - Fee Related
- 1989-10-13 EP EP89202588A patent/EP0365087B1/en not_active Expired - Lifetime
- 1989-10-16 IE IE332489A patent/IE61831B1/en not_active IP Right Cessation
- 1989-10-18 ZA ZA897895A patent/ZA897895B/xx unknown
- 1989-10-19 CA CA002000999A patent/CA2000999A1/en not_active Abandoned
- 1989-10-20 NZ NZ231095A patent/NZ231095A/en unknown
- 1989-10-20 DK DK523589A patent/DK523589A/da not_active Application Discontinuation
- 1989-10-20 FI FI895005A patent/FI100305B/fi not_active IP Right Cessation
- 1989-10-20 AU AU43595/89A patent/AU625802B2/en not_active Ceased
- 1989-10-20 PT PT92071A patent/PT92071B/pt not_active IP Right Cessation
- 1989-10-20 JP JP1274783A patent/JP2807506B2/ja not_active Expired - Lifetime
- 1989-10-21 KR KR1019890015214A patent/KR0151851B1/ko not_active IP Right Cessation
-
1992
- 1992-10-22 GR GR920402373T patent/GR3006048T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK523589A (da) | 1990-04-22 |
| ATE78407T1 (de) | 1992-08-15 |
| AU4359589A (en) | 1990-04-26 |
| NZ231095A (en) | 1992-03-26 |
| FI895005A0 (fi) | 1989-10-20 |
| IE61831B1 (en) | 1994-11-30 |
| GR3006048T3 (pt) | 1993-06-21 |
| KR900005996A (ko) | 1990-05-07 |
| IE893324L (en) | 1990-04-21 |
| AU625802B2 (en) | 1992-07-16 |
| JPH02169523A (ja) | 1990-06-29 |
| DE68902212D1 (de) | 1992-08-27 |
| CA2000999A1 (en) | 1990-04-21 |
| EP0365087A1 (en) | 1990-04-25 |
| EP0365087B1 (en) | 1992-07-22 |
| KR0151851B1 (ko) | 1998-10-15 |
| ZA897895B (en) | 1990-07-25 |
| FI100305B (fi) | 1997-11-14 |
| DE68902212T2 (de) | 1993-05-27 |
| DK523589D0 (da) | 1989-10-20 |
| PT92071B (pt) | 1995-06-30 |
| ES2051989T3 (es) | 1994-07-01 |
| JP2807506B2 (ja) | 1998-10-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX165003B (es) | Procedimiento para la preparacion de conjugados de medicamentos citotoxicos | |
| BR9201015A (pt) | Conjugado de proteina,composto,processo para preparar o conjugado,composicoes farmaceuticas e uso | |
| MX172600B (es) | , "procedimiento para la produccion de una proteina biologicamente activa | |
| ATE107514T1 (de) | Stabilisierte protein- oder peptidkonjugate. | |
| FI884013A0 (fi) | Konjugat av cytokiner med immunoglobuliner. | |
| MX164971B (es) | Procedimiento para la preparacion de conjugados de medicamentos citoxicos | |
| IE861997L (en) | Zwitterionic bicyclic compounds | |
| ATE199167T1 (de) | Nichtglykosyliertes fgf-4 und dieses enthaltende präparate | |
| DE3672950D1 (de) | Thymusextraktfraktionen enthaltende pharmazeutische zusammensetzung. | |
| ES2052893T3 (es) | Preparado de n-acetil-glucosamina para administracion por via bucal. | |
| PT92071A (pt) | Processo de preparacao de imunotoxinas e de preparados farmaceuticos para o tratamento ou profilaxia de doencas auto-imunes | |
| DE69004532D1 (de) | Topisch anzuwendende Defibrotid enthaltende Arzneizubereitungen. | |
| ES2064613T3 (es) | Produccion de agentes citotoxicos. | |
| FR2651435B1 (pt) | ||
| ATE99945T1 (de) | Verwendung von 5'-deoxy-5'-methylthioadenosin s- adenosylmethionin und dessen salzen zur herstellung von seborrhea vermindernden arzneimitteln. | |
| PT557199E (pt) | Conjugados de polietileno glicol hirudina processo de preparacao e uso na cura da trombose | |
| ES2044170T3 (es) | Sal de estroncio, su procedimiento de preparacion y las composiciones farmaceuticas que la contienen. | |
| FI884240A (fi) | Menetelmä paikalliseen käyttöön tarkoitetun farmaseuttisen valmisteen valmistamiseksi | |
| AU1200488A (en) | Protein c inhibitor (pci) as pharmaceutical and in vitro diagnostic aid, a process for the preparation of a pharmaceutical or diagnostic aid of this type, and an agent containing pci | |
| MX9303074A (es) | Uso de la (e)-2-(p-fluorofenetil)-3-fluoroalilamina en el tratamiento de la enfermedad de elzheimer. | |
| SE8802323D0 (sv) | 8alfa-acylaminoergoline, its preparation and pharmaceutical compositions containing it | |
| SE8802084D0 (sv) | Farmaceutiskt preparat och konjugat av en baktericid och en antikropp | |
| IT1209955B (it) | Trattamento di malattie parassitiche | |
| NO903408D0 (no) | Terapeutisk anvendelse av anti-t-celle-immunotoksin for autoimmunsykdommer. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM3A | Annulment or lapse |
Free format text: LAPSE DUE TO NON-PAYMENT OF FEES Effective date: 20000630 |